Eupraxia Pharmaceuticals Inc. Income Statement

Income Statement Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.00B-0.00B31838.97B
Gross Profit -0.00B-0.00B31838.97B
Operating items
Research & Development 0.01B0.02B0.02B
Selling, General & Administrative 0.00B0.01B0.01B
Other Operating Expenses -0.00B-0.00B0.00B
Operating Expenses 0.02B0.03B0.03B
EBIT -0.02B-0.03B-0.03B
Non-operating items
Interest & Investment Income 0.00B0.00B0.00B
Other Non Operating Income 0.00B0.00B-0.00B
Non Operating Income -0.00B-0.00B0.00B
Net income details
EBT -0.02B-0.03B-0.03B
Tax Provisions 0.00B0.00B
Profit After Tax -0.02B-0.03B-0.03B
Income from Non-Controlling Interests -0.00B-0.00B-0.00B
Income from Continuing Operations -0.02B-0.03B-0.03B
Consolidated Net Income -0.02B-0.03B-0.03B
Income towards Parent Company -0.02B-0.03B-0.03B
Net Income towards Common Stockholders -0.02B-0.03B-0.03B
Additional items
EPS (Basic) -0.00B-0.00B-0.00B
EPS (Weighted Average and Diluted) -0.00B-0.00B-0.00B
Shares Outstanding (Weighted Average) 0.03B0.04B
EBITDA -0.02B-0.03B-0.03B